Become a Founding Member for $999 a year, locked for life

    Claim a seat
    MavenlyMavenly

    § Federal grant opportunity · PAR-26-087

    NEI New Innovator Award (DP2 Clinical Trial Not Allowed)

    National Institutes of Health is accepting applications for NEI New Innovator Award (DP2 Clinical Trial Not Allowed). The deadline is Rolling / not published and the published award range is Award amount not published.

    Key facts

    Funder
    National Institutes of Health
    Application deadline
    Rolling / not published
    Award range
    Award amount not published
    Eligibility
    other, private institutions of higher education, public and state institutions of higher education
    Geography
    United States
    Focus areas
    Health
    Opportunity number
    PAR-26-087

    Program overview

    The NEI New Innovator Award supports postdoctoral and other candidates in non-independent equivalent positions or newly independent Early Stage Investigators of exceptional creativity who propose novel, original and insightful research studies within the mission of NEI. Applications responding to this NOFO should have the potential to produce a major impact in vision research, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NEI. Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.

    How to apply

    1. Confirm your organization meets the eligibility criteria above.
    2. Read the full funding opportunity announcement from National Institutes of Health.
    3. Draft your narrative against the funder's stated priorities and review criteria.
    4. Submit before Rolling / not published, allowing time for registration and validation.

    View the official funding announcement

    Find every grant your organization qualifies for

    Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.